AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Studies in the area of life sciences reported from C. Pitsavos and co-researchers.
"We investigated the association of apolipoproteins AI and B in relation to the prevalence of metabolic syndrome in a random sample of cardiovascular disease-free adults from the ATTICA study (1,514 men, aged 18-87 y; 1,528 women, aged 18-89 y)," investigators in Greece report (see also Life Sciences).
"Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. The prevalence of metabolic syndrome was 25% in men and 15% in women (P
The researchers concluded: "Using the area under the Receiver Operation Characteristic curve, apolipoprotein B/AI was the best diagnostic marker of metabolic syndrome, the optimal discriminating cut-off value of this ratio was 0.72 (sensitivity 74%, specificity 67%), and individuals with apolipoprotein B/Al ratio greater than 0.74 had 3.29 times higher odds of having metabolic syndrome (95% confidence interval: 2.56-4.21) after adjusting for potential ...
- KineMed, Inc. Announces Presentation at the Targeting Metabolic Syndrome...
- Press release article from: PR Newswire May 4, 2005 700+ words
...today that it will be presenting at IBC Life Sciences' Targeting Metabolic Syndrome Conference: Exploring New Developments...clinical development of new drugs targeting metabolic syndrome," said David Fineman, President and...
- Study findings from University of Erlangen provide new insights into life...
- Newspaper article from: Diabetes Week March 30, 2009 700+ words
...treatment of the metabolic syndrome,' new data in life sciences. "The metabolic syndrome is a cluster of cardiometabolic...report (see also Life Sciences). "The primary...patients with the metabolic syndrome. Statin therapy...
- Metabolic Syndrome: A New CHA Report Evaluates the Therapeutic and Commercial...
- Press release article from: PR Newswire February 7, 2005 700+ words
...is poised to make metabolic syndrome an unprecedented...information about Metabolic Syndrome: Pipeline Analysis...com/services/Metabolic_Syndrome/overview.cfm...CHA) Advances Life Sciences Reports are written...
- Obesity a National Epidemic; Scientific Exchange: Achieving the Definition of...
- Press release article from: PR Newswire April 20, 2005 700+ words
...business outlook for Metabolic Syndrome * Next generation...world market for metabolic syndrome-related therapeutic...on the Targeting Metabolic Syndrome Conference visit...ibcusa.com. IBC Life Sciences IBC Life Sciences...
- IBC's 3rd Annual Targeting Metabolic Syndrome; Exploring New Developments in...
- Press release article from: PR Newswire March 30, 2005 700+ words
...Annual Targeting Metabolic Syndrome conference will...definition of the Metabolic Syndrome. For up to date...on the Targeting Metabolic Syndrome Conference visit...ibcusa.com. IBC Life Sciences is an independent...
- Researchers to Confer on New Drug Discovery Avenues for Metabolic Syndrome...
- Press release article from: PR Newswire January 5, 2004 700+ words
...that comprise Metabolic Syndrome (also referred...need. IBC Life Sciences, the leading...Conference on Metabolic Syndrome, IBC has...Tools for Metabolic Syndrome Research and...Canney of IBC Life Sciences, pcanney...
- BioLineRx Expands Drug Pipeline with Two Innovative Pre-Clinical Candidates for...
- Press release article from: Business Wire June 20, 2005 700+ words
...metabolic syndrome. Metabolic syndrome, defined as the...animal models of metabolic syndrome, treatment with...for drugs treating metabolic syndrome in the US, Europe...leaders in the Israeli life-sciences sector, BioLineRx...
- Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to...
- Press release article from: PR Newswire March 12, 2008 700+ words
...license agreement with Makoto Life Sciences, Inc., of Cambridge, Massachusetts...hyperlipidemia, obesity, metabolic syndrome and endocrine cancers. About Makoto Life Sciences, Inc. Makoto Life Sciences, Inc. is a leading independent...